• Swine Vaccines Market Trend | Leading Players and Future Prospect

    The New Swine Vaccines Market Report, offering growth, trends, and forecast for each segment along with regional and country analysis. The study has done with respect to market share, size, trends, growth, outlook, estimation and forecast period 2023-2030.


    Browse Full Global Swine Vaccines Market Research Report With TOC At: https://www.valuemarketresearch.com/report/swine-vaccines-market
    Swine Vaccines Market Trend | Leading Players and Future Prospect The New Swine Vaccines Market Report, offering growth, trends, and forecast for each segment along with regional and country analysis. The study has done with respect to market share, size, trends, growth, outlook, estimation and forecast period 2023-2030. Browse Full Global Swine Vaccines Market Research Report With TOC At: https://www.valuemarketresearch.com/report/swine-vaccines-market
    0 Comments 0 Shares
  • Animal Vaccines Market Current Trends, COVID-19 Impact, Future Opportunity, and Forecast 2030

    The Global Animal Vaccines Market Report is a comprehensive and in-depth study on the size, share, growth, trends, demand and estimation with a focus on the latest development. The report provides key statistics on the market status with highlights on various important strategic such as mergers, acquisitions, partnership and other development.

    Browse Global Companion Animal Vaccines Market Research Report with detailed TOC athttps://www.valuemarketresearch.com/report/companion-animal-vaccines-market
    Animal Vaccines Market Current Trends, COVID-19 Impact, Future Opportunity, and Forecast 2030 The Global Animal Vaccines Market Report is a comprehensive and in-depth study on the size, share, growth, trends, demand and estimation with a focus on the latest development. The report provides key statistics on the market status with highlights on various important strategic such as mergers, acquisitions, partnership and other development. Browse Global Companion Animal Vaccines Market Research Report with detailed TOC athttps://www.valuemarketresearch.com/report/companion-animal-vaccines-market
    0 Comments 0 Shares
  • What is the size of synthetic biology market?

    The synthetic biology market is estimated to grow from USD 9.8 billion in 2021 to USD 43.9 billion by 2028 at a healthy CAGR of 23.9% during the forecast period.
    Increasing use of synthetic biology for various applications such as biofuel development, protein therapeutics, personalized medicine, and synthetic drugs & vaccines is one of the prime factors contributing to the demand for synthetic biology.
    Read more: https://www.stratviewresearch.com/846/synthetic-biology-market.html
    What is the size of synthetic biology market? The synthetic biology market is estimated to grow from USD 9.8 billion in 2021 to USD 43.9 billion by 2028 at a healthy CAGR of 23.9% during the forecast period. Increasing use of synthetic biology for various applications such as biofuel development, protein therapeutics, personalized medicine, and synthetic drugs & vaccines is one of the prime factors contributing to the demand for synthetic biology. Read more: https://www.stratviewresearch.com/846/synthetic-biology-market.html
    WWW.STRATVIEWRESEARCH.COM
    Synthetic Biology Market Report Size, Share & Forecast Analysis up to 2028
    The Synthetic Biology Market is estimated to grow from USD 12.1 billion in 2022 to USD 43.9 billion by 2028 at a healthy CAGR of 23.9% during the forecast 2022-2026
    0 Comments 0 Shares
  • $0 - $0 /
    Location
    Type
    Status
    Open
    Durham, NC 27712
    Full-time

    Full Job Description

    Job Description

    Our Quality Assurance group ensures every single material inside our products is manufactured, processed, tested, packaged, stored and distributed aligned with our incredibly high standards of quality and meets all regulatory requirements. Partnering across our internal manufacturing facilities, external contract manufacturers and suppliers we create an interdependent global manufacturing network dedicated to deliver a compliant, reliable supply to customers and patients on time, every time, across the globe.

    We are seeking a Growth and Improvement minded Manufacturing Quality Assurance Associate Specialist that can help drive our Strategic Operating Priorities.

    Invent | Pursue the Most Promising Internal and External Science to Address Significant Unmet Medical Needs

    Execute | Prioritize Resources Behind Our Key Growth Drivers (Oncology, Vaccines, Select Specialty Areas, Animal Health) While Optimizing Our Base Business)

    Adapt | Develop Our People, Culture and Business Model to Evolve with a Dynamic Landscape

    Diverse Talent | We are committed to providing an inclusive and welcoming environment with supporting leadership behaviors because having a high-performing, engaged workforce is critical to our ability to deliver innovative solutions to patients and customers around the world

    Values and Standards | Our Steadfast Commitment to Our Values and Standards will Continue to Guide Us as We Take on New Challenges and Will Always be Fundamental to Our Success – They are a Competitive Advantage for Us
    Durham, NC 27712 Full-time Full Job Description Job Description Our Quality Assurance group ensures every single material inside our products is manufactured, processed, tested, packaged, stored and distributed aligned with our incredibly high standards of quality and meets all regulatory requirements. Partnering across our internal manufacturing facilities, external contract manufacturers and suppliers we create an interdependent global manufacturing network dedicated to deliver a compliant, reliable supply to customers and patients on time, every time, across the globe. We are seeking a Growth and Improvement minded Manufacturing Quality Assurance Associate Specialist that can help drive our Strategic Operating Priorities. Invent | Pursue the Most Promising Internal and External Science to Address Significant Unmet Medical Needs Execute | Prioritize Resources Behind Our Key Growth Drivers (Oncology, Vaccines, Select Specialty Areas, Animal Health) While Optimizing Our Base Business) Adapt | Develop Our People, Culture and Business Model to Evolve with a Dynamic Landscape Diverse Talent | We are committed to providing an inclusive and welcoming environment with supporting leadership behaviors because having a high-performing, engaged workforce is critical to our ability to deliver innovative solutions to patients and customers around the world Values and Standards | Our Steadfast Commitment to Our Values and Standards will Continue to Guide Us as We Take on New Challenges and Will Always be Fundamental to Our Success – They are a Competitive Advantage for Us
    0 Comments 0 Shares
  • $0 - $0 /
    Location
    Type
    Status
    Open
    India

    Job Description :
    Site Name: India - Maharashtra - Nashik Site Posted Date: Jul 5 2022 Ready to help shape the future of healthcare At GSK, we have already delivered unprecedented change over the past four years, improving R&D, becoming a leader in Consumer Healthcare, strengthening our leadership, and transforming our commercial execution. Now, we're making the most significant changes we've made to our business in over 20 years. We're on track to separate and create two new companies in 2022: New GSK with a leading portfolio of vaccines and specialty medicines as well as R&D based on immune system and genetics science and a new world-leading consumer healthcare company of loved and trusted brands. With new ambition comes new purpose. For New GSK, this is to unite science, talent, and technology to get ahead of disease together - all with the clear ambition of delivering human health impact stronger and more sustainable shareholder returns and as a new GSK where outstanding people thrive. Getting ahead means preventing disease as well as treating it. How we do all this is through our people and our culture. A culture that is ambitious for patients - so we deliver what matters better and faster accountable for impact - with clear ownership of goals and support to succeed and where we do the right thing. So, if you're ready to improve the lives of billions, join us at this exciting moment in our journey. Join our challenge to get Ahead Together. Responsibilities- . The incumbent is accountable & responsible for Review of Batch documents & Batch release in accordance with GSK QMS & applicable regulatory requirements and acts as the first contact point for any Quality issues in area of operation. . Ensures compliance and inspection readiness . Ensures release of bulk and finished products, meeting the statutory and QMS requirements, to market . BMR, BPR and analytical reports review and subsequent compliance review, PPA - Trending and release for finished products with performing transactions in dMERP (SAP) system. . Handling of dMERP (SAP) system related to batch release and other QA transactions to enable batch release process is followed as per SOP with status tracking & communications. . Ensures that the manufacturing & packing operations on shop floor are in compliance with regulatory and QMS requirements . Ensures support provided for timely compliance to all audit observations in the area. .
    India Job Description : Site Name: India - Maharashtra - Nashik Site Posted Date: Jul 5 2022 Ready to help shape the future of healthcare At GSK, we have already delivered unprecedented change over the past four years, improving R&D, becoming a leader in Consumer Healthcare, strengthening our leadership, and transforming our commercial execution. Now, we're making the most significant changes we've made to our business in over 20 years. We're on track to separate and create two new companies in 2022: New GSK with a leading portfolio of vaccines and specialty medicines as well as R&D based on immune system and genetics science and a new world-leading consumer healthcare company of loved and trusted brands. With new ambition comes new purpose. For New GSK, this is to unite science, talent, and technology to get ahead of disease together - all with the clear ambition of delivering human health impact stronger and more sustainable shareholder returns and as a new GSK where outstanding people thrive. Getting ahead means preventing disease as well as treating it. How we do all this is through our people and our culture. A culture that is ambitious for patients - so we deliver what matters better and faster accountable for impact - with clear ownership of goals and support to succeed and where we do the right thing. So, if you're ready to improve the lives of billions, join us at this exciting moment in our journey. Join our challenge to get Ahead Together. Responsibilities- . The incumbent is accountable & responsible for Review of Batch documents & Batch release in accordance with GSK QMS & applicable regulatory requirements and acts as the first contact point for any Quality issues in area of operation. . Ensures compliance and inspection readiness . Ensures release of bulk and finished products, meeting the statutory and QMS requirements, to market . BMR, BPR and analytical reports review and subsequent compliance review, PPA - Trending and release for finished products with performing transactions in dMERP (SAP) system. . Handling of dMERP (SAP) system related to batch release and other QA transactions to enable batch release process is followed as per SOP with status tracking & communications. . Ensures that the manufacturing & packing operations on shop floor are in compliance with regulatory and QMS requirements . Ensures support provided for timely compliance to all audit observations in the area. .
    0 Comments 0 Shares
  • $0 - $0 /
    Location
    Type
    Status
    Open
    Durham, NC 27712

    Full Job Description

    Job Description

    Our Quality Assurance group ensures every single material inside our products is manufactured, processed, tested, packaged, stored and distributed aligned with our incredibly high standards of quality and meets all regulatory requirements. Partnering across our internal manufacturing facilities, external contract manufacturers and suppliers we create an interdependent global manufacturing network committed to deliver a compliant, reliable supply to customers and patients on time, every time, across the globe.

    Our Company is expanding its global (HPV) vaccine production network by investing $650 million and adding a 225,000-square-foot building within the footprint of the Maurice R. Hilleman Center for Vaccine Manufacturing in Durham, NC. The new facility will be used to produce the bulk active ingredient for the HPV vaccine, comprised of fermentation, microfiltration/ultrafiltration, and chromatography steps. Approximately 614,000 people are diagnosed with certain HPV-related cancers each year. Our Company manufactures the two HPV vaccines that are predominantly utilized to eradicate these cancers globally. In recent years, countries around the world have enacted new or expanded HPV vaccination programs, which has created an unprecedented increase in global demand. The manufacturing facility in Durham will play a critical role in the network of plants that produce life-saving medicines and vaccines, including our HPV vaccines.

    The Quality Specialist provides expertise in the coordination of resources and equipment pertaining to qualification/validation activities supporting the HPV expansion facility.

    GENERAL PROFILE:

    Position will initially be M-F first shift transitioning to rotational including holidays. Flexibility to work night shift is required.

    Ability to work independently and as a member of a team.

    Contributes to the performance and results of the expansion project.

    Adapts plans and priorities to address resource and operational challenges.

    Decisions are guided by policies, procedures and/or business plans and aligns with management.

    Provides quality guidance to employees, colleagues or clients.

    Anticipates and interprets client and/or customer needs to identify solutions.
    Durham, NC 27712 Full Job Description Job Description Our Quality Assurance group ensures every single material inside our products is manufactured, processed, tested, packaged, stored and distributed aligned with our incredibly high standards of quality and meets all regulatory requirements. Partnering across our internal manufacturing facilities, external contract manufacturers and suppliers we create an interdependent global manufacturing network committed to deliver a compliant, reliable supply to customers and patients on time, every time, across the globe. Our Company is expanding its global (HPV) vaccine production network by investing $650 million and adding a 225,000-square-foot building within the footprint of the Maurice R. Hilleman Center for Vaccine Manufacturing in Durham, NC. The new facility will be used to produce the bulk active ingredient for the HPV vaccine, comprised of fermentation, microfiltration/ultrafiltration, and chromatography steps. Approximately 614,000 people are diagnosed with certain HPV-related cancers each year. Our Company manufactures the two HPV vaccines that are predominantly utilized to eradicate these cancers globally. In recent years, countries around the world have enacted new or expanded HPV vaccination programs, which has created an unprecedented increase in global demand. The manufacturing facility in Durham will play a critical role in the network of plants that produce life-saving medicines and vaccines, including our HPV vaccines. The Quality Specialist provides expertise in the coordination of resources and equipment pertaining to qualification/validation activities supporting the HPV expansion facility. GENERAL PROFILE: Position will initially be M-F first shift transitioning to rotational including holidays. Flexibility to work night shift is required. Ability to work independently and as a member of a team. Contributes to the performance and results of the expansion project. Adapts plans and priorities to address resource and operational challenges. Decisions are guided by policies, procedures and/or business plans and aligns with management. Provides quality guidance to employees, colleagues or clients. Anticipates and interprets client and/or customer needs to identify solutions.
    0 Comments 0 Shares
  • $0 - $0 /
    Location
    Type
    Status
    Open
    Job Description :

    India - Maharashtra - Nashik Site Posted Date: Jul 5 2022 Ready to help shape the future of healthcare At GSK, we have already delivered unprecedented change over the past four years, improving R&D, becoming a leader in Consumer Healthcare, strengthening our leadership, and transforming our commercial execution. Now, we're making the most significant changes we've made to our business in over 20 years. We're on track to separate and create two new companies in 2022: New GSK with a leading portfolio of vaccines and specialty medicines as well as R&D based on immune system and genetics science and a new world-leading consumer healthcare company of loved and trusted brands. With new ambition comes new purpose. For New GSK, this is to unite science, talent, and technology to get ahead of disease together - all with the clear ambition of delivering human health impact stronger and more sustainable shareholder returns and as a new GSK where outstanding people thrive. Getting ahead means preventing disease as well as treating it. How we do all this is through our people and our culture.
    Job Description : India - Maharashtra - Nashik Site Posted Date: Jul 5 2022 Ready to help shape the future of healthcare At GSK, we have already delivered unprecedented change over the past four years, improving R&D, becoming a leader in Consumer Healthcare, strengthening our leadership, and transforming our commercial execution. Now, we're making the most significant changes we've made to our business in over 20 years. We're on track to separate and create two new companies in 2022: New GSK with a leading portfolio of vaccines and specialty medicines as well as R&D based on immune system and genetics science and a new world-leading consumer healthcare company of loved and trusted brands. With new ambition comes new purpose. For New GSK, this is to unite science, talent, and technology to get ahead of disease together - all with the clear ambition of delivering human health impact stronger and more sustainable shareholder returns and as a new GSK where outstanding people thrive. Getting ahead means preventing disease as well as treating it. How we do all this is through our people and our culture.
    0 Comments 0 Shares
  • $0 - $0 /
    Location
    Type
    Status
    Open
    Job Description :
    Site Name: India - Maharashtra - Nashik Site Posted Date: Jul 5 2022 Ready to help shape the future of healthcare At GSK, we have already delivered unprecedented change over the past four years, improving R&D, becoming a leader in Consumer Healthcare, strengthening our leadership, and transforming our commercial execution. Now, we're making the most significant changes we've made to our business in over 20 years. We're on track to separate and create two new companies in 2022: New GSK with a leading portfolio of vaccines and specialty medicines as well as R&D based on immune system and genetics science and a new world-leading consumer healthcare company of loved and trusted brands. With new ambition comes new purpose. For New GSK, this is to unite science, talent, and technology to get ahead of disease together - all with the clear ambition of delivering human health impact stronger and more sustainable shareholder returns and as a new GSK where outstanding people thrive. Getting ahead means preventing disease as well as treating it. How we do all this is through our people and our culture. A culture that is ambitious for patients - so we deliver what matters better and faster accountable for impact - with clear ownership of goals and support to succeed and where we do the right thing. So, if you're ready to improve the lives of billions, join us at this exciting moment in our journey. Join our challenge to get Ahead Together. Responsibilities- . The incumbent is accountable & responsible for Review of Batch documents & Batch release in accordance with GSK QMS & applicable regulatory requirements and acts as the first contact point for any Quality issues in area of operation. . Ensures compliance and inspection readiness . Ensures release of bulk and finished products, meeting the statutory and QMS requirements, to market . BMR, BPR and analytical reports review and subsequent compliance review, PPA - Trending and release for finished products with performing transactions in dMERP (SAP) system. . Handling of dMERP (SAP) system related to batch release and other QA transactions to enable batch release process is followed as per SOP with status tracking & communications. . Ensures that the manufacturing & packing operations on shop floor are in compliance with regulatory and QMS requirements .
    Job Description : Site Name: India - Maharashtra - Nashik Site Posted Date: Jul 5 2022 Ready to help shape the future of healthcare At GSK, we have already delivered unprecedented change over the past four years, improving R&D, becoming a leader in Consumer Healthcare, strengthening our leadership, and transforming our commercial execution. Now, we're making the most significant changes we've made to our business in over 20 years. We're on track to separate and create two new companies in 2022: New GSK with a leading portfolio of vaccines and specialty medicines as well as R&D based on immune system and genetics science and a new world-leading consumer healthcare company of loved and trusted brands. With new ambition comes new purpose. For New GSK, this is to unite science, talent, and technology to get ahead of disease together - all with the clear ambition of delivering human health impact stronger and more sustainable shareholder returns and as a new GSK where outstanding people thrive. Getting ahead means preventing disease as well as treating it. How we do all this is through our people and our culture. A culture that is ambitious for patients - so we deliver what matters better and faster accountable for impact - with clear ownership of goals and support to succeed and where we do the right thing. So, if you're ready to improve the lives of billions, join us at this exciting moment in our journey. Join our challenge to get Ahead Together. Responsibilities- . The incumbent is accountable & responsible for Review of Batch documents & Batch release in accordance with GSK QMS & applicable regulatory requirements and acts as the first contact point for any Quality issues in area of operation. . Ensures compliance and inspection readiness . Ensures release of bulk and finished products, meeting the statutory and QMS requirements, to market . BMR, BPR and analytical reports review and subsequent compliance review, PPA - Trending and release for finished products with performing transactions in dMERP (SAP) system. . Handling of dMERP (SAP) system related to batch release and other QA transactions to enable batch release process is followed as per SOP with status tracking & communications. . Ensures that the manufacturing & packing operations on shop floor are in compliance with regulatory and QMS requirements .
    0 Comments 0 Shares
  • Experts urge Germany's govt to prepare for fall COVID wave:

    Authorities in Germany should prepare for several possible pandemic scenarios this fall that would likely strain the country's health system and critical infrastructure, an expert panel said Wednesday.

    The government-appointed panel said the country continues to have immunity gaps in the population, and it recommended promoting vaccines against the coronavirus and making them more easily available.
    Experts urge Germany's govt to prepare for fall COVID wave: Authorities in Germany should prepare for several possible pandemic scenarios this fall that would likely strain the country's health system and critical infrastructure, an expert panel said Wednesday. The government-appointed panel said the country continues to have immunity gaps in the population, and it recommended promoting vaccines against the coronavirus and making them more easily available.
    WWW.INDEPENDENT.CO.UK
    Experts urge Germany's govt to prepare for fall COVID wave
    An expert panel says authorities in Germany should prepare for several possible pandemic scenarios this fall that would likely strain the country’s health system
    0 Comments 0 Shares
  • Monkeypox becoming established in non-endemic countries warns Tedros;

    calls for more testing, vaccines to end COVID pandemic: At a press conference in Geneva updating on both the current Monkeypox outbreak and COVID-19, WHO Director-General, Tedros Adhanom Ghebreyesus noted that 29 countries where the Monkeypox virus does not usually circulate, had confirmed cases.
    WHO expert and the technical lead for the Monkeypox outbreak, Dr. Rosamund Lewis, said cases being reported now primarily in the non-endemic setting were still “primarily of men who have sex with men.
    Monkeypox becoming established in non-endemic countries warns Tedros; calls for more testing, vaccines to end COVID pandemic: At a press conference in Geneva updating on both the current Monkeypox outbreak and COVID-19, WHO Director-General, Tedros Adhanom Ghebreyesus noted that 29 countries where the Monkeypox virus does not usually circulate, had confirmed cases. WHO expert and the technical lead for the Monkeypox outbreak, Dr. Rosamund Lewis, said cases being reported now primarily in the non-endemic setting were still “primarily of men who have sex with men.
    NEWS.UN.ORG
    Monkeypox becoming established in non-endemic countries warns Tedros; calls for more testing, vaccines to end COVID pandemic
    The World Health Organization (WHO) chief said on Wednesday that monkeypox infections in non-endemic countries have passed the 1,000 mark and the risk of it becoming established in some is “real”.
    0 Comments 0 Shares
More Results
kishan 2